AU1155583A - Bluetongue virus vaccine, method of producing same, and method of immunizing ruminants therewith - Google Patents

Bluetongue virus vaccine, method of producing same, and method of immunizing ruminants therewith

Info

Publication number
AU1155583A
AU1155583A AU11555/83A AU1155583A AU1155583A AU 1155583 A AU1155583 A AU 1155583A AU 11555/83 A AU11555/83 A AU 11555/83A AU 1155583 A AU1155583 A AU 1155583A AU 1155583 A AU1155583 A AU 1155583A
Authority
AU
Australia
Prior art keywords
therewith
virus vaccine
producing same
bluetongue virus
ruminants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11555/83A
Inventor
Charles W. Livingston Jr.
Stewart Mcconnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas A&M University System
Original Assignee
Texas A&M University System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A&M University System filed Critical Texas A&M University System
Publication of AU1155583A publication Critical patent/AU1155583A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU11555/83A 1982-01-19 1983-01-14 Bluetongue virus vaccine, method of producing same, and method of immunizing ruminants therewith Abandoned AU1155583A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34071682A 1982-01-19 1982-01-19
US340716 1982-01-19

Publications (1)

Publication Number Publication Date
AU1155583A true AU1155583A (en) 1983-07-28

Family

ID=23334637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11555/83A Abandoned AU1155583A (en) 1982-01-19 1983-01-14 Bluetongue virus vaccine, method of producing same, and method of immunizing ruminants therewith

Country Status (9)

Country Link
EP (1) EP0098867A1 (en)
JP (1) JPS58502210A (en)
AU (1) AU1155583A (en)
CA (1) CA1226544A (en)
DK (1) DK422783D0 (en)
IL (1) IL67633A0 (en)
NZ (1) NZ203030A (en)
WO (1) WO1983002394A1 (en)
ZA (1) ZA83114B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106636011B (en) * 2016-11-14 2018-07-03 陕西诺威利华生物科技有限公司 A kind of Porcine epidemic diarrhea virus and its application
CN110117579B (en) * 2019-05-29 2021-12-14 军事科学院军事医学研究院军事兽医研究所 Recombinant virus for expressing 16 type bluetongue virus VP2 gene and construction method and application thereof

Also Published As

Publication number Publication date
DK422783A (en) 1983-09-16
DK422783D0 (en) 1983-09-16
NZ203030A (en) 1986-12-05
ZA83114B (en) 1983-12-28
EP0098867A1 (en) 1984-01-25
WO1983002394A1 (en) 1983-07-21
CA1226544A (en) 1987-09-08
JPS58502210A (en) 1983-12-22
IL67633A0 (en) 1983-05-15

Similar Documents

Publication Publication Date Title
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
LTIP1794A (en) Method for the production of an aids virus vaccine
AU588806B2 (en) Drug, and methods of preparing and using it for treatment of tumors
AU560364B2 (en) Method for producing clinker and device for implementing suchmethod
IL71274A0 (en) Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciferol
EP0283505A4 (en) Vaccine and method of preparation.
AU1429583A (en) Photoradiator and method of producing same
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
IL67808A0 (en) Plant-promoting preparations,process for the manufacture thereof and methods for the use thereof
AU568584B2 (en) Infectious bronchitis vaccines
AU2493184A (en) Specific cea-family antigens, antibodies specific thereto and their methods of use
GR82467B (en) Method for the preparation of glyoxal, alkylglyoxales and acetales therefrom
AU2593188A (en) Iminophenylthiazolidines, process of preparation and method of use
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
AU1155583A (en) Bluetongue virus vaccine, method of producing same, and method of immunizing ruminants therewith
EP0218587A4 (en) Monoclonal antibodies and method of immunizing therewith.
AU559212B2 (en) Protein isolates and method of producing them
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
AU1071883A (en) Emulsion copolymers, their method of production, and their use
AU7386887A (en) Method of stimulating the immune system with tolrestat;(n-((5 -(trifluoromethyl)-6-methoxy-1-naphthenyl)thioxomethyl)-n-me hylglycine)
AU8885582A (en) Natural food and method of producing same
IL85645A0 (en) General cancer-associated scm-recognition factor,preparation and method
ZA837819B (en) 1-bromoethyl ethyl carbonate,methods for its preparation and 1-bromoethylchloroformate and 1-bromoethylbromoformate obtained as intermediates
PH17714A (en) Antibiotics x-14873a,g and h and process of producing them
IL68531A0 (en) Method of producing dihydro-1,4-dithin derivatives